ReviewCancer immunology, immunotherapy : CII2018
TIGIT: a novel immunotherapy target moving from bench to bedside.
Benjamin L Solomon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
115 papers cite itlatest 60 shown
this paperpooled itcites it